Drug intelligence / Profile preview

phlomis umbrosa extract

Development stage
Unknown
Lead developer
Naturalendo Tech
Administration
Oral
01

Overview

Phlomis umbrosa extract (PUE) is a botanical extract derived from the perennial herb *Phlomis umbrosa Turcz*, commonly known as Caosu. It is traditionally used in East Asian medicine for its anti-inflammatory and osteogenic properties. The extract contains bioactive compounds such as iridoid glucosides (e.g., shanzhiside methyl ester), triterpenoids, and flavonoids. Research indicates that PUE modulates inflammatory pathways by suppressing the phosphorylation of ERK and p65 (NF-κB), reducing the expression of matrix metalloproteinase-9 (MMP-9), and decreasing levels of inflammatory cytokines. Additionally, it promotes bone growth and health by upregulating Runx2 and other osteogenic markers. While not developed as a proprietary pharmaceutical, it is recognized by the Korean Ministry of Food and Drug Safety as a functional ingredient for promoting longitudinal bone growth in children and has been investigated for treating asthma, osteoporosis, and osteoarthritis.

Other names
Phlomis umbrosa Turczaninow extractCaosu extractP. umbrosa extract
02

Targets

RUNX2RELA (Nuclear Factor Kappa B Subunit p65)MMP9 (Matrix metalloproteinase-9)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on phlomis umbrosa extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phlomis umbrosa extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call